When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level

被引：0
|
作者：
Ugo Giovanni Falagario
Dimple Chakravarty
Alberto Martini
Mohammed Shahait
Ayah El-Fahmawi
Ivan Jambor
Anna Lantz
David Grannas
Parita Ratnani
Sneha Parekh
Dara Lundon
Kenneth Haines
Luigi Cormio
Giuseppe Carrieri
Natasha Kyprianou
Michael W. Kattan
Eric A. Klein
Peter Wiklund
David I. Lee
Ash Tewari
机构：
[1] Icahn School of Medicine at Mount Sinai,Department of Urology
[2] University of Foggia,Department of Urology and Organ Transplantation
[3] Urological Research Institute,Department of Urology
[4] Vita-Salute University,Department of Surgery
[5] San Raffaele Scientific Institute,Department of Surgery, Urology Division
[6] King Hussein Cancer Center,Department of Radiology
[7] University of Pennsylvania,Department of Radiology
[8] Icahn School of Medicine at Mount Sinai,Department of Urology
[9] University of Turku,Department of Medical Epidemiology and Biostatistics
[10] Karolinska University Hospital,Department of Pathology
[11] Karolinska Institute,Department of Urology
[12] Icahn School of Medicine at Mount Sinai,Department of Quantitative Health Sciences
[13] Bonomo Teaching Hospital,Department of Urology
[14] Lerner Research Institute,Department of Urology
[15] Glickman Urological and Kidney Institute,undefined
[16] University of California Irvine,undefined
来源：
World Journal of Urology | 2023年 / 41卷
关键词：
Prostate cancer; Biomarkers; Multiparametric MRI; Decipher test; Genomic tests; Risk stratification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：85 / 92
页数：7
相关论文
共 50 条
  • [1] When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level
    Falagario, Ugo Giovanni
    Chakravarty, Dimple
    Martini, Alberto
    Shahait, Mohammed
    El-Fahmawi, Ayah
    Jambor, Ivan
    Lantz, Anna
    Grannas, David
    Ratnani, Parita
    Parekh, Sneha
    Lundon, Dara
    Haines, Kenneth
    Cormio, Luigi
    Carrieri, Giuseppe
    Kyprianou, Natasha
    Kattan, Michael W.
    Klein, Eric A.
    Wiklund, Peter
    Lee, David I.
    Tewari, Ash
    WORLD JOURNAL OF UROLOGY, 2022, 41 (1) : 85 - 92
  • [2] High-risk prostate cancer: A disease of genomic instability
    Tapia-Laliena, Maria A.
    Korzeniewski, Nina
    Hohenfellner, Markus
    Duensing, Stefan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1101 - 1107
  • [3] External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohort
    Hagens, Marinus J.
    Stelwagen, Piter J.
    Veerman, Hans
    Rynja, Sybren P.
    Smeenge, Martijn
    van der Noort, Vincent
    Roeleveld, Ton A.
    van Kesteren, Jolien
    Remmers, Sebastiaan
    Roobol, Monique J.
    van Leeuwen, Pim J.
    van der Poel, Henk G.
    WORLD JOURNAL OF UROLOGY, 2023, 41 (01) : 13 - 18
  • [4] External validation of the Rotterdam Prostate Cancer Risk Calculator within a Dutch high-risk clinical cohort
    Hagens M.J.
    Stelwagen P.J.
    Veerman H.
    Rynja S.P.
    Smeenge M.
    van der Noort V.
    Roeleveld T.A.
    van Kesteren J.
    Remmers S.
    Roobol M.J.
    van Leeuwen P.J.
    van der Poel H.G.
    Tijdschrift voor Urologie, 2023, 13 (5) : 98 - 105
  • [5] External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohort
    Marinus J. Hagens
    Piter J. Stelwagen
    Hans Veerman
    Sybren P. Rynja
    Martijn Smeenge
    Vincent van der Noort
    Ton A. Roeleveld
    Jolien van Kesteren
    Sebastiaan Remmers
    Monique J. Roobol
    Pim J. van Leeuwen
    Henk G. van der Poel
    World Journal of Urology, 2023, 41 : 13 - 18
  • [6] Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model
    Thurtle, David R.
    Greenberg, David C.
    Lee, Lui S.
    Huang, Hong H.
    Pharoah, Paul D.
    Gnanapragasam, Vincent J.
    PLOS MEDICINE, 2019, 16 (03)
  • [7] Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation
    Hansen, Jens
    Becker, Andreas
    Kluth, Luis A.
    Rink, Michael
    Steuber, Thomas
    Zacharias, Mario
    Briganti, Alberto
    Fisch, Margit
    Graefen, Markus
    Chun, Felix K. -H.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (09) : 384.e1 - 384.e8
  • [8] Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study
    Diamand, Romain
    Roche, Jean-Baptiste
    Lacetera, Vito
    Simone, Giuseppe
    Windisch, Olivier
    Benamran, Daniel
    Fourcade, Alexandre
    Fournier, Georges
    Fiard, Gaelle
    Ploussard, Guillaume
    Roumeguere, Thierry
    Peltier, Alexandre
    Albisinni, Simone
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [9] Development and validation of a model for predicting the risk of prostate cancer
    Ya-Dong Li
    Zheng-ju Ren
    Yuan-Qing Gou
    Chuan Wei-Tan
    Liang Liu
    International Urology and Nephrology, 2024, 56 : 973 - 980
  • [10] Development and External Validation of Multiparametric MRI-Derived Nomogram to Predict Risk of Pathologic Upgrade in Patients on Active Surveillance for Prostate Cancer
    Kim, See Hyung
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 214 (04) : 825 - 834
12345